Mitsutoshi Kato

770 total citations
30 papers, 401 citations indexed

About

Mitsutoshi Kato is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mitsutoshi Kato has authored 30 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mitsutoshi Kato's work include Sodium Intake and Health (6 papers), Blood Pressure and Hypertension Studies (6 papers) and Diabetes Treatment and Management (6 papers). Mitsutoshi Kato is often cited by papers focused on Sodium Intake and Health (6 papers), Blood Pressure and Hypertension Studies (6 papers) and Diabetes Treatment and Management (6 papers). Mitsutoshi Kato collaborates with scholars based in Japan, Canada and United States. Mitsutoshi Kato's co-authors include K. J. Kako, Nobuyuki Abe, Hideo Tachibana, Masatoshi Kikuchi, Shinji Terao, Hideharu Ishida, Makoto Kiso, Akira Hasegawa, Shigeru Kageyama and Toshiyuki Hayakawa and has published in prestigious journals such as Diabetes, Scientific Reports and International Journal of Heat and Mass Transfer.

In The Last Decade

Mitsutoshi Kato

29 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsutoshi Kato Japan 11 168 130 84 75 51 30 401
Mary F. Carroll United States 7 196 1.2× 81 0.6× 28 0.3× 40 0.5× 97 1.9× 8 458
Kimmo Malminiemi Finland 12 55 0.3× 79 0.6× 168 2.0× 63 0.8× 58 1.1× 26 418
Kelvin Kuan Huei Ng Canada 7 78 0.5× 162 1.2× 63 0.8× 33 0.4× 47 0.9× 10 363
P. K. Nigam India 10 84 0.5× 70 0.5× 59 0.7× 35 0.5× 68 1.3× 19 386
Björn Wahlstrand Sweden 11 104 0.6× 151 1.2× 122 1.5× 25 0.3× 89 1.7× 13 404
Chuchun L. Chang United States 14 96 0.6× 107 0.8× 87 1.0× 187 2.5× 126 2.5× 25 502
V Sathiyapriya India 13 124 0.7× 80 0.6× 63 0.8× 35 0.5× 29 0.6× 23 358
Şenay Topsakal Türkiye 11 115 0.7× 64 0.5× 37 0.4× 32 0.4× 62 1.2× 49 360
Yifei Dong China 10 68 0.4× 51 0.4× 90 1.1× 49 0.7× 60 1.2× 50 363
Martin P. Bedigian United States 9 353 2.1× 97 0.7× 480 5.7× 38 0.5× 55 1.1× 15 680

Countries citing papers authored by Mitsutoshi Kato

Since Specialization
Citations

This map shows the geographic impact of Mitsutoshi Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsutoshi Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsutoshi Kato more than expected).

Fields of papers citing papers by Mitsutoshi Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsutoshi Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsutoshi Kato. The network helps show where Mitsutoshi Kato may publish in the future.

Co-authorship network of co-authors of Mitsutoshi Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsutoshi Kato. A scholar is included among the top collaborators of Mitsutoshi Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsutoshi Kato. Mitsutoshi Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kario, Kazuomi, Hiroyuki Ohbayashi, Naoki Itabashi, et al.. (2025). Home blood pressure-lowering effect of esaxerenone vs trichlormethiazide for uncontrolled hypertension: a prespecified subanalysis of the EXCITE-HT randomized controlled study by age subgroup. Hypertension Research. 48(4). 1586–1598. 2 indexed citations
2.
3.
Katsuya, Tomohiro, Yoshito Inobe, Kazuaki Uchiyama, et al.. (2024). Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study. Hypertension Research. 47(4). 835–848. 13 indexed citations
4.
Kario, Kazuomi, Masafumi Nishizawa, Mitsutoshi Kato, et al.. (2023). Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study. Hypertension Research. 46(7). 1782–1794. 15 indexed citations
5.
Watanabe, Yasuhiro, Daisuke Suzuki, Nobuichi Kuribayashi, et al.. (2021). A randomized controlled trial of two diets enriched with protein or fat in patients with type 2 diabetes treated with dapagliflozin. Scientific Reports. 11(1). 11350–11350. 5 indexed citations
6.
Fujihara, Kazuya, Chika Horikawa, Mitsutoshi Kato, et al.. (2019). Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study. Diabetes Therapy. 10(3). 1133–1138.
7.
8.
Satoh, Michihiro, Miki Hosaka, Takuya Tsuchihashi, et al.. (2014). Validity of salt intake assessment system based on a 24-h dietary recall method using a touch panel computer. Clinical and Experimental Hypertension. 36(7). 471–477. 3 indexed citations
9.
Kato, Mitsutoshi, et al.. (2013). Structured self‐monitoring of blood glucose reduces glycated hemoglobin in insulin‐treated diabetes. Journal of Diabetes Investigation. 4(5). 450–453. 27 indexed citations
10.
Kikuchi, Masatoshi, et al.. (2009). Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 83(2). 233–240. 81 indexed citations
11.
Yokota, Kuninobu, et al.. (2004). Clinical Efficacy of Magnesium Supplementation in Patients with Type 2 Diabetes. Journal of the American College of Nutrition. 23(5). 506S–509S. 60 indexed citations
12.
Hirata, Tetsuo, et al.. (2000). Crystal ice formation of solution and its removal phenomena at cooled horizontal solid surface. International Journal of Heat and Mass Transfer. 43(5). 757–765. 15 indexed citations
13.
Hasegawa, Akira, Mitsutoshi Kato, Takashi Ando, Hideharu Ishida, & Makoto Kiso. (1995). Synthesis of sialyl lewis X ganglioside analogues containing modified l-fucose residues. Carbohydrate Research. 274. 165–181. 10 indexed citations
14.
Hasegawa, Akira, et al.. (1994). Synthesis of deoxy-l-fucose-containing sialyl Lewis X ganglioside analogues. Carbohydrate Research. 257(1). 67–80. 23 indexed citations
15.
Hasegawa, Akira, et al.. (1994). Synthesis of the methyl thioglycosides of 2-,3-, and 4-deoxy-l-fucose. Carbohydrate Research. 257(1). 55–65. 5 indexed citations
16.
Takeda, Nobuakira, et al.. (1993). Beneficial effect of ACE inhibitor in congestive heart failure. Molecular and Cellular Biochemistry. 129(2). 139–143. 5 indexed citations
17.
Takeda, Nobuakira, et al.. (1993). Mitochondrial DNA deletion in human myocardium. Molecular and Cellular Biochemistry. 119(1-2). 105–108. 15 indexed citations
18.
Kato, Mitsutoshi, et al.. (1993). Abnormalities of ADP/ATP carrier protein in J-2-N cardiomyopathic hamsters. Molecular and Cellular Biochemistry. 119(1-2). 89–94. 2 indexed citations
19.
Kato, Mitsutoshi, Nobuakira Takeda, Jie Yang, & Makoto Nagano. (1992). The effects of angiotensin converting enzyme inhibitors and the role of the Renin-Angiotensin-Aldosterone system in J-2-N cardiomyopathic hamsters.. Japanese Circulation Journal. 56(1). 46–51. 9 indexed citations
20.
Kato, Mitsutoshi & K. J. Kako. (1987). Orientation of vesicles isolated from baso-lataral membranes of renal cortex. Molecular and Cellular Biochemistry. 78(1). 9–16. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary F. Carroll Breakdown of academic impact, for papers by Kimmo Malminiemi Breakdown of academic impact, for papers by Kelvin Kuan Huei Ng Breakdown of academic impact, for papers by P. K. Nigam Breakdown of academic impact, for papers by Björn Wahlstrand Breakdown of academic impact, for papers by Chuchun L. Chang Breakdown of academic impact, for papers by V Sathiyapriya Breakdown of academic impact, for papers by Şenay Topsakal Breakdown of academic impact, for papers by Yifei Dong Breakdown of academic impact, for papers by Martin P. Bedigian
Rankless by CCL
2026